Cornerstone Therapeutics Inc.
(NASDAQ : CRTX)

( )
CRTX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading CRTX News...
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
1.68%35.021.4%$913.45m
JNJJohnson & Johnson
0.91%119.300.8%$878.06m
ABBVAbbVie, Inc.
3.02%61.801.7%$588.13m
MRKMerck & Co., Inc.
2.59%57.021.0%$558.87m
BMYBristol-Myers Squibb Company
1.33%72.971.1%$480.65m
LLYEli Lilly and Company
3.98%78.140.8%$367.90m
GSKGlaxoSmithKline plc Sponsored ADR
2.75%42.470.2%$179.44m
NVSNovartis AG Sponsored ADR
1.99%81.170.2%$158.94m
AZNAstraZeneca PLC Sponsored ADR
2.58%29.840.9%$154.38m
SNYSanofi Sponsored ADR
1.85%41.300.2%$103.20m
NVONovo Nordisk A/S Sponsored ADR Class B
1.46%52.990.1%$85.43m
LCILannett Company, Inc.
-0.38%23.6627.9%$17.01m
SCMPSucampo Pharmaceuticals, Inc. Class A
-0.64%10.854.1%$6.08m
AKTXAkari Therapeutics Plc Sponsored ADR
-6.80%13.550.2%$0.07m
EPIXESSA Pharma Inc
0.00%2.900.0%$0.01m

Company Profile

Cornerstone Therapeutics, Inc. is a specialty pharmaceutical company, which is focused on commercializing products for the hospital, niche respiratory and related specialty markets. It acquires, develops and commercializes prescription pharmaceutical drugs. The company was founded on October 31, 2008 and is headquartered in Cary, NC.